Herb-Drug Combinations: A New Complementary Therapeutic Strategy
Autor Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Dobleen Limba Engleză Hardback – 6 oct 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 695.07 lei 6-8 săpt. | |
Springer Nature Singapore – 7 oct 2023 | 695.07 lei 6-8 săpt. | |
Hardback (1) | 702.00 lei 6-8 săpt. | |
Springer Nature Singapore – 6 oct 2022 | 702.00 lei 6-8 săpt. |
Preț: 702.00 lei
Preț vechi: 738.95 lei
-5% Nou
Puncte Express: 1053
Preț estimativ în valută:
134.35€ • 141.33$ • 112.10£
134.35€ • 141.33$ • 112.10£
Carte tipărită la comandă
Livrare economică 09-23 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811951244
ISBN-10: 9811951241
Pagini: 276
Ilustrații: XV, 276 p. 1 illus.
Dimensiuni: 155 x 235 mm
Greutate: 0.59 kg
Ediția:1st ed. 2022
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
ISBN-10: 9811951241
Pagini: 276
Ilustrații: XV, 276 p. 1 illus.
Dimensiuni: 155 x 235 mm
Greutate: 0.59 kg
Ediția:1st ed. 2022
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
Cuprins
Chapter 1. Introduction.- Chapter 2. Measuring Herb-drug interaction and Synergy.- Chapter 3. Herb-Herb and Food-drug interactions.- Chapter 4. Pharmacokinetic interactions in synergistic herb-drug combinations.- Chapter 5. Antagonistic Herb-drug interactions.- Chapter 6. Synergistic Herb-drug interactions against bacteria.- Chapter 7. Synergistic herb-drug interactions against tuberculosis.- Chapter 8. Synergistic herb-drug interactions against viral diseases.- Chapter 9. Synergistic herb interactions with cardiovascular drugs.- Chapter 10. Synergistic herb interactions with anticancer drugs.- Chapter 11. Synergistic herb interactions with antidiabetic drugs.- Chapter 12. Synergistic herb-drug interactions against obesity.- Chapter 13. Synergistic Herb-Drug Interactions in Neurological Disorders.- Chapter 14. Synergistic Herb-drug interactions with antifungal and antiparasitic agents.- Chapter 15. Computational methods to study herb-drug interactions.- Chapter 16. Regulations and guidelines involving synergistic plant-drug interactions.- Chapter 17. Clinical trials on synergistic herb-drug interactions.- Chapter 18. QFuture prospects on synergistic herb-drug interactions.- Chapter 19. Conclusion.
Notă biografică
Prof. Mukesh Doble is a Distinguished Professor, Saveetha Dental College & Hospitals and Professor (retd) Department of Biotechnology at the Indian Institute of Technology, Madras, India. His areas of interest are biomaterials, drug design, and bioreactors. He holds B.Tech/M. Tech degrees in Chemical Engineering from IIT, Madras, a Ph. D. from Aston University, UK and postdoctoral from University of Cambridge, U.K., and Texas A&M, U.S.A. He has published 350 technical papers, 10 books, and filed 20 patents. He is a Director of two start-up companies in biotechnology. He is a fellow of Royal Society of Chemistry, London, a recipient of Herdillia Award for “Excellence in Basic Research” from Indian Institute of Chemical Engineers and 5th National Award for Technology Innovation in Field of Petrochemicals and Downstream Plastic Processing Industry, GoIndia for “Antimicrobial Food Wrap”. He is one amongst the World’s Top 2% Scientists (list published by Stanford University, USA, 2021).
Dr. Shanmugam Hemaiswarya is a Project Officer at the Department of Biotechnology, Indian Institute of Technology, Madras. She did her PhD from the Department of Biotechnology, IIT Madras. Her research interests include phytomedicine and studying combinations of phytochemicals within extracts or with synthetic drugs. She did her postdoctoral at University of Algarve, Portugal and a three-year research fellowship (Women Scientist Scheme A, DST) at Anna University, Chennai. She has 23 research publications to her credit.
Dr. Pranav Kumar Prabhakar is working as Professor in Lovely Professional University Punjab, India. He completed his master in biochemistry from Patna University Bihar and his Ph.D. in Biotechnology from Indian Institute of Technology (IIT) Madras. His research interests include synergy, phytomedicine, metabolic disorders. He is serving as an editorial member of several reputed journals. He has authored 60+ research articles, two edited books and 11 book chapters. He is member of Royal Society of Chemistry, Indian Science Congress Association, and Asia-Pacific Chemical, Biological& Environmental Engineering Society.
Dr. Shanmugam Hemaiswarya is a Project Officer at the Department of Biotechnology, Indian Institute of Technology, Madras. She did her PhD from the Department of Biotechnology, IIT Madras. Her research interests include phytomedicine and studying combinations of phytochemicals within extracts or with synthetic drugs. She did her postdoctoral at University of Algarve, Portugal and a three-year research fellowship (Women Scientist Scheme A, DST) at Anna University, Chennai. She has 23 research publications to her credit.
Dr. Pranav Kumar Prabhakar is working as Professor in Lovely Professional University Punjab, India. He completed his master in biochemistry from Patna University Bihar and his Ph.D. in Biotechnology from Indian Institute of Technology (IIT) Madras. His research interests include synergy, phytomedicine, metabolic disorders. He is serving as an editorial member of several reputed journals. He has authored 60+ research articles, two edited books and 11 book chapters. He is member of Royal Society of Chemistry, Indian Science Congress Association, and Asia-Pacific Chemical, Biological& Environmental Engineering Society.
Textul de pe ultima copertă
Plant extracts or their pure natural constituents have been used traditionally for thousands of years for treating diseases with considerable success in India and other Asian countries. In addition, they have also been used as complements or supplements with conventional medicine. This book discusses the latest research in the application of combination therapy, namely herbs and drugs, in the treatment of a range of communicable and non-communicable diseases to achieve a synergistic effect. This synergy may help in reducing the amount of drug, its toxicity, side effects, and development of resistance as well as improve its efficacy. The book also discusses the pharmacodynamic and pharmacokinetic parameters, experimental tools to determine the impact of combination, computational approaches to identify synergy, statistical analysis of data, and clinical and regulatory issues. The book is useful for researchers in the fields of pharmacology, pharmacy and medicinal chemistry and those working in pharmaceutical and nutraceutical industries. This book could open up new strategies to focus on multiple targets to combat complex diseases unlike the single targeted drugs that are being currently marketed by the pharmaceuticals industries.
Caracteristici
Focuses on synergistic combinations of phytochemicals and synthetic drugs which can lead to enhanced performance Describes synergism between commercial drugs Includes the pharmacokinetic interactions that bring about synergisitic interactions